Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$991000.0.

  • Biomerica's Free Cash Flow fell 2528.45% to -$991000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$3.0 million, marking a year-over-year increase of 4074.74%. This contributed to the annual value of -$3.8 million for FY2025, which is 2902.81% up from last year.
  • Per Biomerica's latest filing, its Free Cash Flow stood at -$991000.0 for Q4 2025, which was down 2528.45% from -$268000.0 recorded in Q3 2025.
  • Biomerica's Free Cash Flow's 5-year high stood at $2.3 million during Q1 2022, with a 5-year trough of -$4.3 million in Q2 2022.
  • Its 5-year average for Free Cash Flow is -$951591.0, with a median of -$1.0 million in 2021.
  • Examining YoY changes over the last 5 years, Biomerica's Free Cash Flow showed a top increase of 26635.16% in 2022 and a maximum decrease of 237314.52% in 2022.
  • Biomerica's Free Cash Flow (Quarter) stood at $1.3 million in 2021, then plummeted by 193.02% to -$1.2 million in 2022, then skyrocketed by 31.45% to -$848000.0 in 2023, then grew by 6.72% to -$791000.0 in 2024, then decreased by 25.28% to -$991000.0 in 2025.
  • Its Free Cash Flow stands at -$991000.0 for Q4 2025, versus -$268000.0 for Q3 2025 and -$661000.0 for Q2 2025.